Author

Yue Zhong

Tisch Cancer InstituteORCID 0000-0003-2101-8632Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Research Focus:perturbation response prediction· 1 Assay:proteomics· 1

Frequent Co-Authors

Alba Bundo· 1 shared Alicia Yue· 1 shared Changzhong Jin· 1 shared Ernesto GuccioneiD· 1 shared Jian Jun JiniD· 1 shared Kuan-lin HuangiD· 1 shared Md Kabir· 1 shared Mingye FengiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alba Bundo

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintMay 6, 2026

Multispecific nanobody degraders co-deplete membrane receptors and enable targeted delivery of diverse payloads

Md Kabir, Yong Joon (Jeffrey) Kim, Zhijie Deng…·Yi Shi

This paper develops MINDS, a multispecific nanobody-Fc platform that co-depletes membrane receptors and delivers diverse payloads, showing improved antitumor activity in cancer models.

DOI 10.64898/2026.05.02.722401

humanproteomics

𝕏 PostBluesky